Sounds good to me, let them be the guinea pigs. The ultra-rich and influential seem to be a renewable resource so it’s not like society will run out, if there are risks not found by tests thus far it won’t be swept under the rug, and they are not so numerous that they will make a serious impact on the supply chain.
Aside from the massive number of testers in Phase 3 trials across the globe?
What number counts as massive?
Initial results [0] on Moderna’s are on 95 participants in a trial with 30k [1] due to run to 10/22. I’ll be happy to monitor results and ADE rates before taking the plunge although I’m really excited about the promise of mRNA.
0. https://www.nih.gov/news-events/news-releases/promising-inte...